Rosiglitazone increases the concentration of large, buoyant but not small dense LDL in patients with type 2 diabetes and coronary artery disease




Lautamaki R, Ronnemaa T, Airaksinen KEJ, Leino A, Hiekkanen H, Stewart M, Knuuti J, Nuutila P

PublisherOXFORD UNIV PRESS

2005

 European Heart Journal

EUROPEAN HEART JOURNAL

EUR HEART J

26

224

224

1

0195-668X




Last updated on 26/11/2024 02:02:35 PM